Animate Biosciences Inc. has released promising preclinical results from a mouse model of pulmonary fibrosis demonstrating that two of its AI-designed therapeutic peptides significantly reduced lung ...

"What started as something asymptomatic for the majority of my life turned into a lingering cough, which turned to chest pains, bouts of coughing up blood, then at times, struggling to breathe," she ...

Animation has always enjoyed a devoted following, but 2025’s releases revealed that its audience is bigger and broader than most of us thought. In a tough year for most live-action releases, one of ...

Lakers fans have been eagerly awaiting the return of LeBron James, who has yet to make his 2025-26 season debut while dealing with sciatica. Last week, James was assigned to the G-League to ...

Christy Houvouras exercises daily, eats right and has smoked fewer than 20 cigarettes in her lifetime. That’s why she was shocked when she was diagnosed with lung cancer at just 36 years old in July. ...

Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...

Researchers uncovered how lung cells decide whether to rebuild tissue or fight infection. This built-in “switch” may be the key to restoring the lungs’ natural repair ability. The discovery could lead ...

CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...

Keith Rochfort receives funding from Research Ireland. As colder months set in, respiratory infections begin to climb: everything from the common cold and flu to COVID. It’s a time when healthy lungs ...

Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with the potential to reshape how we study disease, move beyond animal testing, ...